Form 4: Harvard Bioscience Director Alan I. Edrick Acquires Restricted Stock Units

Director Alan I. Edrick acquired 45,872 restricted stock units in Harvard Bioscience Inc. on May 21, 2024.

Summary

• On May 21, 2024, Alan I. Edrick, a director of Harvard Bioscience Inc., acquired 45,872 restricted stock units.
• These restricted stock units will fully vest on the earlier of the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and May 21, 2025.
• Following the transaction, Edrick beneficially owns a total of 273,911 shares of common stock, including the newly acquired restricted stock units and 228,039 shares already held.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction of restricted stock units to a director. It suggests confidence but doesn't provide strong positive or negative signals.

Positives

• The acquisition of restricted stock units by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is tied to future events, specifically the next Annual Meeting of Stockholders or May 21, 2025.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment as it indicates a director's investment in the company.

Key Dates